Clinical features of transplant patients
| Patient/ age/sex | Diagnosis | Time after transplant (days) | Non-ocular opportunistic diseases | CMV status | |||||
|---|---|---|---|---|---|---|---|---|---|
| Donor | Recipient | ||||||||
| 1/53/M | ARN | 400 | BCC, herpes simplex 1 | Negative | Positive | ||||
| 2/56/M | ARN | 892 | Candida oesophagitis, BCC | Positive | Positive | ||||
| 3/43/F | ARN | 402 | Oral candidiasis, oral herpes simplex, thoracic herpes zoster | Positive | Positive | ||||
| 4/51/M | ARN | 282 | Nil | Negative | Positive | ||||
| 5/52/M | ARN | 326 | Nil | Positive | Negative | ||||
| 6/36/M | CMV | 473 | CMV enteritis, CMV marrow disease | Positive | Positive | ||||
| 7/55/M | CMV | 151 | CMV hepatitis, oral herpes simplex | Positive | Positive | ||||
| 8/50/M | CMV | 190 | Aspergillus pneumonia | Positive | Positive | ||||
| 9/53/F | Fungal | 147 | Nil | Positive | Positive | ||||
| 10/57/M | Fungal | 255 | Oral herpes simplex, CMVgastritis/myocarditis | Negative | Negative | ||||
| 11/36/F | Herpetic keratitis | 1210 | Nil | Positive | Negative | ||||
| 12/63/M | Herpetic keratitis | 1482 | Nil | Positive | Positive | ||||
| 13/37/F | PTLD | 123 | CMV hepatitis | Positive | Positive | ||||
| 14/53/M | HZO | 950 | Tinea versicolor | Negative | Positive | ||||
| 15/62/M | CRVO | 440 | BCC/SCC | Positive | Negative | ||||
| 16/62/M | Dacryocystitis | 1179 | BCC oral herpes simplex, olfactory neuroblastoma | Negative | Positive | ||||
| 17/26/M | RV | 213 | Tinea versicolor | Positive | Positive | ||||
| 18/54/M | Cyclosporin retinopathy | 2272 | Nil | Positive | Positive | ||||
| 19/56/F | Rifabutin uveitis | 603 | MAI thrombophlebitis | Negative | Negative | ||||
ARN = acute retinal necrosis; CMV = cytomegalovirus; PTLD = post-transplant lymphoproliferative disorder; HZO = herpes zoster ophthalmicus; CRVO = central retinal vein occlusion; RV = retinal vasculitis; BCC = basal cell carcinoma: SCC = squamous cell carcinoma